Results 251 to 260 of about 1,876,726 (306)

Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injections. [PDF]

Eur J Health Econ
Manders EA, van Der Wel V, Schlingemann R, Hollak CEM, de Visser SJ.   +4 more
europepmc   +1 more source

Diagnosis-Related group payment and its impact on hospitalization costs and patient financial protection for neurointerventional stroke care in a Chinese tertiary hospital: a retrospective analysis. [PDF]

Cost Eff Resour Alloc
Chen Z, Zhang T, Meng K, Guan H, Xu B.
europepmc   +1 more source

Health insurance in Nigeria: Findings from the People's Voice Survey. [PDF]

PLOS Glob Public Health
Croke K, Nwangwu C, Fasawe OB, Aniebo I, Ladhani K, Kruk ME, Filani O.   +6 more
europepmc   +1 more source

Evaluating Environmental and Economic Perspectives of Hybrid Energy Storage Systems: A Review. [PDF]

ACS Omega
Paračková M, Pechancová V, Sáha P, Oriňaková R.   +3 more
europepmc   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

China's carbon emission trading and income inequality: evidence from factor substitution. [PDF]

Carbon Balance Manag
He S, Jiang L, Li M, Liu J.
europepmc   +1 more source

Health Expenditures, Human Capital, and Sustainable Development: Panel Evidence From the New EU Member Countries

Sustainability, 2023
Both health and human capital are simultaneously resources and indicators of sustainable development. Therefore, this research article studies the causal interaction among total health expenditures, out-of-pocket expenditures, human capital, and ...
Mahmut Unsal Şaşmaz, Gamze Sart, Yilmaz Bayar   +2 more
exaly   +2 more sources

CAPITALIZING R&D EXPENDITURES [PDF]

Macroeconomic Dynamics, 2010
The next international version of the System of National Accounts will recommend that R&D (Research and Development) expenditures be capitalized instead of being immediately expensed as in the present System of National Accounts 1993. An R&D project creates a new technology, which in principle does not depreciate like a reproducible asset.
Diewert, Erwin, Huang, Ning
openaire   +1 more source